Biomodulators in cancer treatment.
Department of Medicine, University of Southern California School of Medicine 90033.
M S
MS
Mitchell
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D007376:Interleukin-2; D007372:Interferons